down arrow

Cryo-Cell International, Inc.

  • Market Cap: Micro Cap
  • Industry: Transport Services
  • ISIN: US2288951088
USD
3.95
0.1 (2.6%)

Dec 04

ASE

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

3.713.98

52 Week

3.578.86
Valuation
Technical
Day's Volume

CASH

1.92 k

Shareholding (May 2025)

FII

0.39%

Held by 3 FIIs

DII

92.2%

Held by 2 DIIs

Promoter

5.08%

How big is Cryo-Cell International, Inc.?

22-Jun-2025

As of Jun 18, Cryo-Cell International, Inc. has a market capitalization of 70.88 million, with recent net sales of 32.10 million and a net profit of 0.13 million over the last four quarters. The company's shareholder's funds are -13.22 million, and total assets are 64.68 million as of Nov'24.

Market Cap: As of Jun 18, Cryo-Cell International, Inc. has a market capitalization of 70.88 million, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, the sum of Net Sales is 32.10 million, while the sum of Net Profit is 0.13 million.<BR><BR>Balance Sheet Snapshot: As of Nov'24, the Shareholder's Funds are reported at -13.22 million, and the Total Assets amount to 64.68 million.

Read More

What does Cryo-Cell International, Inc. do?

22-Jun-2025

Cryo-Cell International, Inc. is a micro-cap company in the transport services industry, with recent net sales of $8 million and a market cap of $70.88 million. It is currently loss-making, with a P/E ratio of NA and a dividend yield of 0.00%.

Overview: <BR>Cryo-Cell International, Inc. operates in the transport services industry and is classified as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 8 Million (Quarterly Results - Feb 2025) <BR>Most recent Net Profit: 0 Million (Quarterly Results - Feb 2025) <BR>Market-cap: USD 70.88 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.68 <BR>Return on Equity: 2.12% <BR>Price to Book: -4.84<BR><BR>Contact Details: <BR>Registrar Address: Not available.

Read More

Is Cryo-Cell International, Inc. overvalued or undervalued?

25-Jun-2025

As of October 18, 2022, Cryo-Cell International, Inc. is considered overvalued and has a risky financial outlook due to its negative P/E ratio, high EV to EBITDA ratio, and poor stock performance compared to peers and the S&P 500.

As of 18 October 2022, the valuation grade for Cryo-Cell International, Inc. moved from fair to risky, indicating a significant downgrade in its financial outlook. The company appears to be overvalued based on its current metrics, particularly given its negative P/E ratio and price-to-book value of -5.02. Additionally, the EV to EBITDA ratio stands at 15.97, which is notably high compared to its peers.<BR><BR>In comparison to similar companies, Cryo-Cell's valuation is starkly unfavorable; for instance, Bristow Group, Inc. has a P/E of 9.07 and an EV to EBITDA of 7.42, showcasing a more attractive investment profile. Other peers, such as Seacor Marine Holdings, Inc. and ModivCare, Inc., also reflect risky valuations but with less severe metrics than Cryo-Cell. Given these factors, the company is assessed as overvalued, particularly in light of its poor stock performance relative to the S&P 500, where it has underperformed significantly over the past year and beyond.

Read More

Is Cryo-Cell International, Inc. technically bullish or bearish?

20-Sep-2025

As of September 8, 2025, Cryo-Cell International, Inc. is in a bearish trend, indicated by negative signals from moving averages and Bollinger Bands, despite a mildly bullish weekly KST, and has significantly underperformed the S&P 500 with a year-to-date return of -39.27%.

As of 8 September 2025, the technical trend for Cryo-Cell International, Inc. has changed from mildly bearish to bearish. The current stance is bearish, with key indicators supporting this view including a bearish signal from the daily moving averages, bearish readings on both weekly and monthly Bollinger Bands, and a monthly bearish MACD. Additionally, the KST shows a mildly bullish signal on the weekly timeframe but remains bearish monthly, indicating mixed signals across different periods. The stock has underperformed the S&P 500 significantly, with a year-to-date return of -39.27% compared to the S&P 500's 12.22%, and a 3-year return of -40.00% versus 70.41% for the benchmark.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Transport Services

stock-summary
Market cap

USD 61 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.71

stock-summary
Return on Equity

2.12%

stock-summary
Price to Book

-3.93

Revenue and Profits:
Net Sales:
8 Million
(Quarterly Results - May 2025)
Net Profit:
0 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-14.87%
0%
-14.87%
6 Months
-21.16%
0%
-21.16%
1 Year
-55.27%
0%
-55.27%
2 Years
-29.59%
0%
-29.59%
3 Years
-12.22%
0%
-12.22%
4 Years
-67.6%
0%
-67.6%
5 Years
-47.33%
0%
-47.33%

Cryo-Cell International, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News

Is Cryo-Cell International, Inc. technically bullish or bearish?

As of 8 September 2025, the technical trend for Cryo-Cell International, Inc. has changed from mildly bearish to bearish. The current stance is bearish, with key indicators supporting this view including a bearish signal from the daily moving averages, bearish readings on both weekly and monthly Bollinger Bands, and a monthly bearish MACD. Additionally, the KST shows a mildly bullish signal on the weekly timeframe but remains bearish monthly, indicating mixed signals across different periods. The stock has underperformed the S&P 500 significantly, with a year-to-date return of -39.27% compared to the S&P 500's 12.22%, and a 3-year return of -40.00% versus 70.41% for the benchmark....

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0.19%
EBIT Growth (5y)
-10.37%
EBIT to Interest (avg)
1.97
Debt to EBITDA (avg)
3.02
Net Debt to Equity (avg)
-0.71
Sales to Capital Employed (avg)
-4.79
Tax Ratio
100.00%
Dividend Payout Ratio
510.20%
Pledged Shares
0
Institutional Holding
12.98%
ROCE (avg)
60.29%
ROE (avg)
36.59%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-5.02
EV to EBIT
20.73
EV to EBITDA
15.97
EV to Capital Employed
-17.93
EV to Sales
2.60
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : May 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Strategic Entities

Domestic Funds

Held in 4 Schemes (2.32%)

Foreign Institutions

Held by 3 Foreign Institutions (0.39%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - May'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "May'25",
        "Nov'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7.90",
          "val2": "8.00",
          "chgp": "-1.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.80",
          "val2": "0.20",
          "chgp": "800.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.60",
          "val2": "0.70",
          "chgp": "-14.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.40",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.40",
          "val2": "-1.90",
          "chgp": "121.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "188.30%",
          "val2": "-15.40%",
          "chgp": "20.37%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Nov'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Nov 2024 is 2.24% vs 3.30% in Nov 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Nov 2024 is 104.21% vs -439.29% in Nov 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Nov'24",
        "Nov'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "32.00",
          "val2": "31.30",
          "chgp": "2.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4.80",
          "val2": "1.50",
          "chgp": "220.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.90",
          "val2": "1.20",
          "chgp": "58.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.90",
          "val2": "-11.90",
          "chgp": "107.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.40",
          "val2": "-9.50",
          "chgp": "104.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "118.50%",
          "val2": "-7.90%",
          "chgp": "12.64%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - May'25 - QoQstock-summary
May'25
Nov'24
Change(%)
Net Sales
7.90
8.00
-1.25%
Operating Profit (PBDIT) excl Other Income
1.80
0.20
800.00%
Interest
0.60
0.70
-14.29%
Exceptional Items
-0.40
0.00
Consolidate Net Profit
0.40
-1.90
121.05%
Operating Profit Margin (Excl OI)
188.30%
-15.40%
20.37%
USD in Million.
stock-summary Compare with Peers
Net Sales

Not Applicable: The company has declared_date for only one period

Consolidated Net Profit

Not Applicable: The company has declared_date for only one period

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Nov'24stock-summary
Nov'24
Nov'23
Change(%)
Net Sales
32.00
31.30
2.24%
Operating Profit (PBDIT) excl Other Income
4.80
1.50
220.00%
Interest
1.90
1.20
58.33%
Exceptional Items
0.90
-11.90
107.56%
Consolidate Net Profit
0.40
-9.50
104.21%
Operating Profit Margin (Excl OI)
118.50%
-7.90%
12.64%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Nov 2024 is 2.24% vs 3.30% in Nov 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Nov 2024 is 104.21% vs -439.29% in Nov 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Cryo-Cell International, Inc. stock-summary
stock-summary
Cryo-Cell International, Inc.
Transport Services
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."